Article
In vitro evolution predicts that the IMP-1 metallo-beta-lactamase does not have the potential to evolve increased activity against imipenem.
Antimicrobial agents and chemotherapy - 1 Mar 2004
Hall Barry G
Abstract excerpt
In vitro evolution was used to predict whether the IMP-1 metallo-beta-lactamase has the potential to evolve an increased ability to confer resistance to imipenem. Screening of eight libraries containing 9.8 x 10(6) +/- 1.4 x 10(6) (mean +/- standard error) variants per library, with an average of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
